Search Results 1121-1130 of 25282 for Pulmonary
Chief Fellow - Pulmonary and Critical Care Medicine FellowshipBanner University Medical Center Phoenix, University of Arizona College of Medicine.
Clinical Trials · A Study to Evaluate the Effectiveness and Safety of Pamrevlumab in Patients with Idiopathic Pulmonary Fibrosis · More about research at Mayo ...
How can I best manage the symptoms and live as fully as possible with this condition? ANSWER: Chronic obstructive pulmonary disease, or COPD, is a leading cause ...
The instructors are certified pulmonary function technologists, respiratory therapists, and physicians, each with more than 10 years of experience in pulmonary ...
Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis. Chest ...
The purpose of this trial is to evaluate the effectiveness and safety of pamrevlumab in subjects with idiopathic pulmonary fibrosis (IPF). Subjects who were ...
While treatments exist to slow the progression of pulmonary fibrosis, lung transplantation is the only cure. Since Robert's lung transplant, which took ...
Quit smoking, or don't start. Smoking is the leading cause of chronic obstructive pulmonary disease, also called COPD. If you have COPD, quitting can slow ...
... pulmonary fibrosis (IPF), a potentially fatal lung disease that necessitated ... pulmonary evaluation. Both sisters' conditions were deteriorating ...
Treatment of Pulmonary hypertension · Hypertensive heart disease · Congestive heart failure in high-risk populations: diabetics, females, African Americans ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.